5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The Optogenetics Market is segmented by Light Equipment (Laser and Light-emitting Diode), Actuator, Sensor, Application, and Geography.
Fastest Growing Market:
The optogenetics market is expected to register a CAGR of nearly 16.0% during the forecast period, 2019-2024. The major factors driving the growth of the market include the scope of optogenetics as a potential diagnostic tool in the field of neurosciences, rapid growth of advanced technologies, and the increasing use of multimodal imaging.
As per the scope of this report, optogenetics refers to a range of optical techniques, used to elicit a physiological response in targeted biological systems, in the absence of pharmacology and electric stimulations. Optogenetics controls the neural activity by combining genetic engineering and optical tools, and is widely used in neuroscience for the modulation of neural circuits with a high degree of precision and specificity.
|Light-emitting Diode (LED)|
|Calcium (Aequorin, Cameleon, and Other Calcium Sensors)|
|Retinal Disease Treatment|
Report scope can be customized per your requirements. Click here.
LEDs are found to surpass lasers in every aspect, as they are cheaper, smaller, more reliable, and easier to control. They are being incorporated into implants, allowing untethered light delivery. However, the major drawback, and the reason that they have not been as widely adopted in the field of optogenetics is due to the difficulty in coupling the light with a fiber optic cable, with high efficiency. Although individual LEDs can emit as much as five watts of light, the light is emitted in all directions, rather than in a coherent beam. These are among the major factors that are restricting the growth of the segment in the market. However, a recent class of fiber-coupled LEDs offers much higher intensities of fiber-coupled light. Hence, there are many advancements, in both LED technologies and their applications. Effective LED therapies are used in treating cutaneous and neurological diseases. The researchers in LEDs, imaging, light therapy, and optogenetics have understood the basic principles, and hence, they are stimulating the applications of LEDs in healthcare.
To understand key trends, Download Sample Report
North America is expected to lead the market, owing to the increase in use of optogenetic devices, primarily in academic and research labs. There is a rise in the number of neuronal diseases, such as epilepsy, in the United States, with at least 2.9 million adults and children being affected, and a steady increase in the number of neuropsychiatric disorders, which are expected to drive the growth of the optogenetic market. Currently, the most common application of optogenetics is with live animals. Additionally, it is rapidly being used in various academic and research labs across the United States, which helps in driving the market, globally. Many advancements in neuroscience are made possible by the BRAIN initiative (Brain Research through Advancing Innovative Neurotechnologies), which is a massive, collaborative, private-public funded project aimed at gaining a better understanding of the human brain. In 2014, the US federal budget committed USD 100 million to the BRAIN initiative, and has been increased the funding by USD 100 million each year, since 2014. Such initiatives may open new doors that may boost the US optogenetics market. In 2016, the RetroSense Therapeutics completed the low-dose cohort in the clinical trial of novel gene therapy application of optogenetics. Hence, all the aforementioned factors have helped in the growth of the market.
To understand geography trends, Download Sample Report.
The market is moderately consolidated, owing to the presence of various small and large players. Some of the market players are Addgene, Cobolt Inc., Coherent Inc., Gensight Biologics, Laserglow Technologies, Noldus Information Technology, Scientifica, Shanghai Laser & Optics Century Co. Ltd, and Thorlabs Inc.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Potential Diagnostic Tool in the Field of Neurosciences
4.2.2 Rapid Growth of Advanced Technology
4.2.3 Increasing Use of Multimodal Imaging
4.3 Market Restraints
4.3.1 High Cost of Technology
4.3.2 Lack of Awareness
4.3.3 Reluctance in the Adoption of New Technologies
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 Light Equipment
5.1.2 Light-emitting Diode (LED)
5.3.1 Calcium (Aequorin, Cameleon, and Other Calcium Sensors)
5.3.2 Chloride (Clomeleon)
5.3.3 Membrane-gated (Mermaid)
5.3.4 Other Sensors
5.4.2 Behavioral Tracking
5.4.3 Retinal Disease Treatment
5.4.4 Other Applications
5.5.1 North America
22.214.171.124 Rest of Europe
126.96.36.199 South Korea
188.8.131.52 Rest of Asia-Pacific
5.5.4 Middle East and Africa
184.108.40.206 South Africa
220.127.116.11 Rest of Middle East & Africa
5.5.5 South America
18.104.22.168 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Cobolt Inc.
6.1.2 Coherent Inc.
6.1.3 Gensight Biologics
6.1.4 Laserglow Technologies
6.1.5 Noldus Information Technology
6.1.7 Shanghai Laser & Optics Century Co. Ltd
6.1.8 The Jackson Laboratory
6.1.9 Thorlabs Inc.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape Covers - Business Overview, Financials, Products, Strategies, and Recent Developments